STRATAGEM: Strategy for Managing Antiplatelet Therapy in the Perioperative Period of Non Coronary Surgery "STRATAGEM"

Completed

Phase 4 Results N/A

Summary of Purpose

The STRATAGEM trial is an investigator-driven French nationwide multicenter, randomized, double-blind, placebo-controlled trial comparing perioperative low-dose aspirin therapy versus placebo in the perioperative period in patients with documented symptomatic stable atherothrombotic disease taking antiplatelet therapy and undergoing non-coronary surgery.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 September 2011.

1 Jun 2005 12 Sep 2005 1 Dec 2009 1 Dec 2009 1 Sep 2005 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver)
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • 1st Contact: Nathalie Garin Phone: 33 1 40 25 73 85 Email: nathalie.garin@bch.aphp.fr 2nd Contact: Florence Tubach, MD Phone: 33 1 40 25 62 54 Email: florence.tubach@bch.aphp.fr 3rd Contact: Souhayl Dahmani, MD Phone: 33 1 40 87 59 11 Email: souhayl.dahmani@bjn.aphp.fr

    nathalie.garin@bch.aphp.fr